Skip to main content
Matty Rypto Photo
Mahathir Bayena

Mahathir Bayena

GrafaCrypto Journalist

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.

Articles by Mahathir Bayena

Grafa

European Commission approves Dupixent for children aged 2–11 with chronic spontaneous urticaria

Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) announced on April 13, 2026, that the European Commission, has expanded the marketing authorization for Dupixent (dupilumab) to include children aged 2 to 11 years with moderate-to-severe chronic spontaneous urticaria (CSU).

Read more: European Commission approves Dupixent for children aged 2–11 with chronic spontaneous urticaria